BILIARY CANCER

Clinical trials for BILIARY CANCER explained in plain language.

Never miss a new study

Get alerted when new BILIARY CANCER trials appear

Sign up with your email to follow new studies for BILIARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New hope for bile duct cancer: Four-Drug cocktail trial launches

Disease control Recruiting now

This study tests a new drug (CDX-1140) combined with three existing drugs (capecitabine, oxaliplatin, and Keytruda) in adults with advanced biliary tract cancer that has worsened after standard treatment. The goal is to find a safe dose and see if the combination can shrink tumor…

Matched conditions: BILIARY CANCER

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 06, 2026 16:15 UTC

BILIARY CANCER

Get alerted when new BILIARY CANCER trials appear

New hope for bile duct cancer: Four-Drug cocktail trial launches